Laura Kenny

3.0k total citations
52 papers, 1.8k citations indexed

About

Laura Kenny is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Laura Kenny has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Laura Kenny's work include Medical Imaging Techniques and Applications (23 papers), Glioma Diagnosis and Treatment (9 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). Laura Kenny is often cited by papers focused on Medical Imaging Techniques and Applications (23 papers), Glioma Diagnosis and Treatment (9 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). Laura Kenny collaborates with scholars based in United Kingdom, United States and Netherlands. Laura Kenny's co-authors include Eric O. Aboagye, R. Charles Coombes, Adil Al‐Nahhas, Sami Shousha, David M. Vigushin, Kaiyumars Contractor, Safiye Osman, Carlo Palmieri, Federico Turkheimer and Justin Stebbing and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Laura Kenny

48 papers receiving 1.8k citations

Peers

Laura Kenny
Michael Burchmore United States
Azeem Saleem United Kingdom
Ben‐Quan Shen United States
Brent N. Rexer United States
Songji Zhao Japan
Hakim Bouterfa Germany
Thomas Holbro Switzerland
Neil A. O’Brien United States
Cammie Rinehart United States
Timothy D. Shafman United States
Michael Burchmore United States
Laura Kenny
Citations per year, relative to Laura Kenny Laura Kenny (= 1×) peers Michael Burchmore

Countries citing papers authored by Laura Kenny

Since Specialization
Citations

This map shows the geographic impact of Laura Kenny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Kenny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Kenny more than expected).

Fields of papers citing papers by Laura Kenny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Kenny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Kenny. The network helps show where Laura Kenny may publish in the future.

Co-authorship network of co-authors of Laura Kenny

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Kenny. A scholar is included among the top collaborators of Laura Kenny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Kenny. Laura Kenny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Edison, Paul, et al.. (2023). Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management. BMJ. 380. e071726–e071726. 36 indexed citations
3.
Balachandran, K., Ashley Brown, Sarah Mahmoud, et al.. (2021). 176P Breast cancer treatment during the first wave of the COVID-19 pandemic at a UK centre. Annals of Oncology. 32. S94–S94. 1 indexed citations
4.
Lythgoe, Mark P., Jonathan Krell, Laura Kenny, & Ali Raza Khaki. (2021). 157P Racial diversity and reporting in FDA registration trials for breast cancer from 2006 to 2021. Annals of Oncology. 32. S88–S88. 1 indexed citations
5.
6.
Naidoo, Kuban D., Y. Yiangou, Philippe Donatien, et al.. (2019). Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Magnani, Luca, Narumi Harada‐Shoji, Francesco Mauri, et al.. (2019). FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Scientific Reports. 9(1). 1505–1505. 102 indexed citations
8.
Krämer, G., Adrianus J. de Langen, Elise P. Jansma, et al.. (2018). Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 951–961. 7 indexed citations
9.
Palmieri, Carlo, Richard Szydlo, Laura Barker, et al.. (2017). IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer. Breast Cancer Research and Treatment. 166(2). 527–539. 25 indexed citations
10.
Blighe, Kevin, Laura Kenny, Naina Patel, et al.. (2014). Whole Genome Sequence Analysis Suggests Intratumoral Heterogeneity in Dissemination of Breast Cancer to Lymph Nodes. PLoS ONE. 9(12). e115346–e115346. 16 indexed citations
11.
Kenny, Laura, Giampaolo Tomasi, Federico Turkheimer, et al.. (2014). Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [18F]fluciclatide kinetics and [15O]H2O PET. EJNMMI Research. 4(1). 30–30. 3 indexed citations
12.
Challapalli, Amarnath, Laura Kenny, William Hallett, et al.. (2013). 18F-ICMT-11, a Caspase-3–Specific PET Tracer for Apoptosis: Biodistribution and Radiation Dosimetry. Journal of Nuclear Medicine. 54(9). 1551–1556. 74 indexed citations
13.
Monteiro, Lara J., Pasarat Khongkow, Mesayamas Kongsema, et al.. (2012). The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment. Oncogene. 32(39). 4634–4645. 80 indexed citations
14.
Contractor, Kaiyumars, Laura Kenny, R. Charles Coombes, et al.. (2012). Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data. EJNMMI Research. 2(1). 11–11. 15 indexed citations
15.
Contractor, Kaiyumars, Amarnath Challapalli, Tara Barwick, et al.. (2011). Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression. Clinical Cancer Research. 17(24). 7673–7683. 96 indexed citations
16.
Contractor, Kaiyumars, Laura Kenny, Justin Stebbing, et al.. (2011). [18F]-3′Deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel. Clinical Cancer Research. 17(24). 7664–7672. 68 indexed citations
17.
Kenny, Laura, Kaiyumars Contractor, Rainer Hinz, et al.. (2010). Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab. Clinical Cancer Research. 16(16). 4236–4245. 42 indexed citations
18.
Kenny, Laura, Kaiyumars Contractor, Justin Stebbing, et al.. (2009). Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography. Clinical Cancer Research. 15(21). 6649–6657. 49 indexed citations
19.
Kenny, Laura, R. Charles Coombes, Inger Oulie, et al.. (2008). Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients. Journal of Nuclear Medicine. 49(6). 879–886. 237 indexed citations
20.
Kenny, Laura, R. Charles Coombes, David M. Vigushin, et al.. (2007). Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 34(9). 1339–1347. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Burchmore Breakdown of academic impact, for papers by Azeem Saleem Breakdown of academic impact, for papers by Ben‐Quan Shen Breakdown of academic impact, for papers by Brent N. Rexer Breakdown of academic impact, for papers by Songji Zhao Breakdown of academic impact, for papers by Hakim Bouterfa Breakdown of academic impact, for papers by Thomas Holbro Breakdown of academic impact, for papers by Neil A. O’Brien Breakdown of academic impact, for papers by Cammie Rinehart Breakdown of academic impact, for papers by Timothy D. Shafman
Rankless by CCL
2026